BIOMAT Database Logo BIOMAT Database Logo

Overview of a workshop on quantitative models for developmental toxicity risk assessment. 1989

C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC 20460.

A workshop was held to discuss potential advancements to improve the precision of risk estimates for developmental toxicity. This paper presents an overview of the discussions at the workshop, focusing on the risk assessment process and science policy considerations important in the use of quantitative models. Some of the pertinent biological considerations are reviewed, particularly those related to the repair capacity of the developing organism and how this affects the concept of a threshold for developmental toxicity effects, as well as the maternal and litter influences on developmental toxicity outcomes. Finally, the current status of use of quantitative approaches is described, possible short-term approaches are discussed, and future research needs in this area are outlined.

UI MeSH Term Description Entries
D008452 Maximum Allowable Concentration The maximum exposure to a biologically active physical or chemical agent that is allowed during an 8-hour period (a workday) in a population of workers, or during a 24-hour period in the general population, which does not appear to cause appreciable harm, whether immediate or delayed for any period, in the target population. (From Lewis Dictionary of Toxicology, 1st ed) Maximum Permissible Exposure Level,MPEL,Maximum Permissible Exposure Concentration,Allowable Concentration, Maximum,Allowable Concentrations, Maximum,Concentration, Maximum Allowable,Concentrations, Maximum Allowable,MPELs,Maximum Allowable Concentrations
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004785 Environmental Pollutants Substances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS. Environmental Pollutant,Pollutant,Pollutants,Pollutants, Environmental,Pollutant, Environmental
D004787 Environmental Pollution Contamination of the air, bodies of water, or land with substances that are harmful to human health and the environment. Pollution, Environmental,Soil Pollution,Pollution, Soil
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000014 Abnormalities, Drug-Induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. Drug-Induced Abnormalities,Abnormalities, Drug Induced,Abnormality, Drug-Induced,Drug Induced Abnormalities,Drug-Induced Abnormality

Related Publications

C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
Quantitative risk assessment for developmental toxicity.
March 1992, Biometrics,
C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
Biologically based risk assessment models for developmental toxicity.
January 2000, Methods in molecular biology (Clifton, N.J.),
C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
Summary of the workshop on issues in risk assessment: quantitative methods for developmental toxicology.
August 1994, Risk analysis : an official publication of the Society for Risk Analysis,
C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
An overview of maritime waterway quantitative risk assessment models.
March 2012, Risk analysis : an official publication of the Society for Risk Analysis,
C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
Assessment of developmental toxicity potential of chemicals by quantitative structure-toxicity relationship models.
July 1995, Chemosphere,
C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
An overview of developmental and reproductive toxicity risk assessment in China.
February 2010, Birth defects research. Part B, Developmental and reproductive toxicology,
C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
Developmental immunotoxicology and risk assessment: a workshop summary.
January 2002, Human & experimental toxicology,
C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
Applications of multinomial dose-response models in developmental toxicity risk assessment.
August 1994, Risk analysis : an official publication of the Society for Risk Analysis,
C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
Workshop overview: arsenic research and risk assessment.
August 2007, Toxicology and applied pharmacology,
C A Kimmel, and D G Wellington, and W Farland, and P Ross, and J M Manson, and N Chernoff, and J F Young, and S G Selevan, and N Kaplan, and C Chen
Overview: Workshop on children's inhalation dosimetry and health effects for risk assessment.
January 2008, Journal of toxicology and environmental health. Part A,
Copied contents to your clipboard!